Guinea vs Mexico: The number of people with susceptibility test result for rifampicin
Guinea
4,242
in 2021
Mexico
4,205
in 2021
Guinea rank
33rd
Mexico rank
34th
The number of people with susceptibility test result for rifampicin over time
- Guinea
- Mexico
How they compare
Guinea currently reports 4,242 against 4,205 in Mexico, a difference of 37.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Guinea ahead.
Guinea ranks 33rd and Mexico ranks 34th of 155 countries.
Across the 2 decades both report, Guinea averaged higher in 1 and Mexico in 1.
Head to head by decade
| Decade | Guinea | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,430 | 183.67 | 1,246 | Guinea |
| 2020s | 2,200 | 3,240 | 1,040 | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guinea or Mexico?
- Guinea, at 4,242 against 4,205 in Mexico as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guinea and Mexico?
- 37, with Guinea ahead.
- How many years of comparable data are there for Guinea and Mexico?
- 5 years are reported by both, from 2017 to 2021.
- How do Guinea and Mexico rank globally for the number of people with susceptibility test result for rifampicin?
- Guinea ranks 33rd and Mexico ranks 34th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.